|
Investor Materials
For Institutional Investors and Media:
Press Releases:
| Aug-17-2010
|
Palatin Technologies, Inc. Announces Positive Safety Results in Subcutaneous Bremelanotide Trial in Men |
 |
|
| Jun-25-2010
|
Palatin Technologies, Inc. To Raise $2.0 Million Dollars In Registered Direct Offering |
|
|
| Jun-24-2010
|
Palatin Technologies, Inc. Announces Last Patient Dosed And Database Lock In Subcutaneous Bremelanotide Trial In Men |
|
|
| Jun-21-2010
|
Palatin Technologies, Inc. Announces Positive Preclinical Data with PL-3994 for Asthma Indications
|
|
|
| May-13-2010
|
Palatin Technologies, Inc. Reports Third Quarter Fiscal Year 2010 Results; Teleconference and Webcast to be held on May 13, 2010
|
|
|
| May-13-2010
|
Palatin Technologies, Inc. Reports Third Quarter Fiscal Year 2010 Results; Teleconference and Webcast to be held on May 13, 2010
|
|
|
| May-11-2010
|
Palatin Technologies, Inc. To Report Fiscal Year 2010 Third Quarter Results;
Teleconference and Webcast to be held on May 13, 2010 |
|
|
| May-04-2010
|
Palatin Technologies, Inc. Issued U.S. Patent And
Receives Patent Allowance On Seven Additional Patents
|
|
|
 |
|
|
